Prober Charles J. 4
4 · Life360, Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Life360 (LIF) Director Charles J. Prober Exercises Options, Sells Shares
What Happened
- Charles J. Prober, a director of Life360, exercised options and immediately sold the resulting shares. On Feb 13, 2026 he exercised 7,930 option shares at a strike of $11.18 (cost = $88,657) and sold those 7,930 shares in the open market at $49.02 for gross proceeds of $388,729. The filing shows the related derivative (the option) was disposed/cancelled as part of the exercise.
Key Details
- Transaction date: 2026-02-13.
- Option exercise: 7,930 shares acquired at $11.18 per share (total cost reported $88,657).
- Open-market sale: 7,930 shares sold at $49.02 per share (gross proceeds $388,729).
- Derivative disposition: 7,930 option units shown as disposed (reflects the option being exercised/cancelled).
- Shares owned after transaction: Not disclosed in this Form 4 filing.
- Notable footnotes:
- F1: Sale was effected under a Rule 10b5‑1 trading plan adopted Mar 14, 2025 (pre‑established plan; adopted when the filer stated they were not aware of material nonpublic information).
- F2: Filing references 1,357 restricted stock units previously granted (each converts to one share upon vesting).
- F3: Option vesting schedule described (initial 1/2 vested Apr 1, 2024; remainder vesting monthly thereafter).
- Filing timeliness: Transaction filed on 2026-02-18 for activity on 2026-02-13 — outside the standard two‑business‑day Form 4 window, so the filing appears late.
Context
- This was an exercise-plus-sale (often called a cashless exercise or exercise-and-sell) where the insider converted options into shares and sold them immediately. Such transactions frequently reflect routine liquidity or tax/settlement needs rather than a directional view on the stock; the pre-established 10b5‑1 plan further indicates the sales were automated under preset rules.
Insider Transaction Report
Form 4
Prober Charles J.
Director
Transactions
- Exercise/Conversion
Common stock
[F1][F2]2026-02-13$11.18/sh+7,930$88,657→ 113,386 total - Sale
Common stock
[F1][F2]2026-02-13$49.02/sh−7,930$388,729→ 105,456 total - Exercise/Conversion
Stock Option (right to buy)
[F1][F3]2026-02-13−7,930→ 71,370 totalExercise: $11.18Exp: 2028-04-12→ Common stock (7,930 underlying)
Footnotes (3)
- [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
- [F2]Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F3]The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Signature
/s/ Jay Sood, Attorney-in-Fact|2026-02-18